SCHEMBL7006392

SCHEMBL7006392

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)NC(=O)c4ccncc4)ccc3OCC)nc12

nearest known ligand 0.75

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.75
PDE5A O76074 16/20 0.70
KMT2A Q03164 1/20 0.69
HDAC1 Q13547 4/20 0.68
HDAC6 Q9UBN7 4/20 0.68
HDAC2 Q92769 3/20 0.68
PDE6C P51160 2/20 0.68
PDE2A O00408 1/20 0.68
PDE9A O76083 1/20 0.68
PDE4A P27815 1/20 0.68
PDE1A P54750 1/20 0.68
PDE11A Q9HCR9 1/20 0.68
PDE10A Q9Y233 1/20 0.68
HDAC3 O15379 1/20 0.67
NCOR2 Q9Y618 1/20 0.67
ABCC5 O15440 1/20 0.66
POLB P06746 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002595 0.95 KDM4E (0.67) KDM4EPDE5AKMT2AHDAC1HDAC6
SCHEMBL7000157 0.93 KDM4E (0.76) KDM4EPDE5AKMT2AHDAC1HDAC6
SCHEMBL7003778 0.92 KDM4E (0.62) KDM4EPDE5AKMT2AHDAC1HDAC6
SCHEMBL7004586 0.92 KDM4E (0.74) KDM4EPDE5AKMT2AHDAC1HDAC6
SCHEMBL7004779 0.91 KDM4E (0.71) KDM4EPDE5AKMT2AHDAC1HDAC6
SCHEMBL7001089 0.91 KDM4E (0.61) KDM4EPDE5AKMT2AHDAC1HDAC6
SCHEMBL7002705 0.91 KDM4E (0.73) KDM4EPDE5AKMT2AHDAC1HDAC6
SCHEMBL7001505 0.91 KDM4E (0.72) KDM4EPDE5AKMT2AHDAC1HDAC6
SCHEMBL7000746 0.88 KDM4E (0.80) KDM4EPDE5AKMT2AHDAC1HDAC6
SCHEMBL7004511 0.88 KDM4E (0.68) KDM4EPDE5AKMT2AHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716298-B2 Composition for reducing skin wrinkles including PDE5 inhibitor SK CHEMICALS CO., LTD. (KR) 2014-05-06 US claimed
EP-2556820-A2 COMPOSITION CONTAINING PDE5 INHIBITOR FOR RELIEVING SKIN WRINKLES SK Chemicals, Co., Ltd. (KR) 2013-02-13 EP claimed
US-20130030174-A1 COMPOSITION FOR REDUCING SKIN WRINKLES INCLUDING PDE5 INHIBITOR SK CHEMICALS CO., LTD. (KR) 2013-01-31 US claimed
EP-1129093-B1 PYRAZOLOPYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF IMPOTENCE DONG A PHARM CO LTD (KR) 2003-07-23 EP claimed
US-6583147-B1 5-(2-ethoxy-5-(isopropylamidosulfonyl)phenyl)-1-methyl-3-propy l- 1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one; DONG A PHARM CO., LTD. (KR) 2003-06-24 US claimed
US-9155691-B2 Composition for reducing skin wrinkles including PDE5 inhibitor SK CHEMICALS CO., LTD. (KR) 2015-10-13 US disclosed
US-20140179701-A1 COMPOSITION FOR REDUCING SKIN WRINKLES INCLUDING PDE5 INHIBITOR SK CHEMICALS CO., LTD. (KR) 2014-06-26 US disclosed
US-8716298-B2 Composition for reducing skin wrinkles including PDE5 inhibitor SK CHEMICALS CO., LTD. (KR) 2014-05-06 US disclosed
US-20130030174-A1 COMPOSITION FOR REDUCING SKIN WRINKLES INCLUDING PDE5 INHIBITOR SK CHEMICALS CO., LTD. (KR) 2013-01-31 US disclosed
EP-1129093-B1 PYRAZOLOPYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF IMPOTENCE DONG A PHARM CO LTD (KR) 2003-07-23 EP disclosed
US-6583147-B1 5-(2-ethoxy-5-(isopropylamidosulfonyl)phenyl)-1-methyl-3-propy l- 1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one; DONG A PHARM CO., LTD. (KR) 2003-06-24 US disclosed